Poisons Standard July 2016

Overview

The Therapeutic Goods Act 1989 was enacted to establish a comprehensive system for controlling the quality, safety, efficacy, and timely availability of therapeutic goods in Australia, as well as to provide a framework for states and territories to uniformly control the availability and accessibility of medicines and poisons. This legislation aims to ensure the safe handling of these substances and to mitigate the risks of poisoning and misuse through a system of access controls. Administered by the Therapeutic Goods Administration, the Act facilitates expert advisory committees, the Advisory Committee on Medicines Scheduling and the Advisory Committee on Chemicals Scheduling, which provide recommendations on scheduling decisions. The Poisons Standard, integral to the Act, outlines the scheduling of substances and their control measures, and is used by states and territories for regulatory purposes. The July 2016 amendment to the Poisons Standard was introduced to correct an error in the previous standard, specifically addressing the omission of pentobarbitone and the inclusion of ‘phenobarbit’ in Appendix K, while also making minor editorial amendments. This update ensures the Poisons Standard aligns with international naming conventions and corrects typographical errors, reflecting the Act's commitment to maintaining accurate and effective regulatory standards.

Scope and Application

The Therapeutic Goods Act 1989 (TG Act) governs the quality, safety, efficacy, and timely availability of therapeutic goods used or exported from Australia, with the Therapeutic Goods Administration (TGA) administering the Act. It establishes a framework for states and territories to adopt a uniform approach to the control and safe handling of medicines and poisons. The Poisons Standard, as outlined in the Act, classifies substances into schedules that dictate the level of control over their availability to the public. This classification is pivotal for placing restrictions on the supply of scheduled substances, aiming to minimise risks of poisoning and misuse. The Poisons Standard July 2016, which replaces the June 2016 version, corrects an error by updating the substance name from pentobarbitone to pentobarbital and removes an incorrect reference. The Poisons Standard is a legislative instrument under the Legislative Instruments Act 2003 but is not subject to disallowance or scrutiny for human rights compatibility. This instrument commenced on 1 July 2016.

Key Provisions

The main operative sections of the Therapeutic Goods Act 1989 (TG Act) are particularly relevant in understanding the administration and control of therapeutic goods, including medicines and poisons, within Australia. Section 52D(2) empowers the Secretary to the Department of Health or a delegate to amend the Poisons Standard or prepare a new one, replacing the current standard. This legislative power ensures the Poisons Standard can be updated to reflect current health and safety considerations, as evidenced by the correction made in the July 2016 Poisons Standard to rectify an error from the previous month. The Act also establishes expert advisory committees, such as the Advisory Committee on Medicines Scheduling (ACMS) (section 52B) and the Advisory Committee on Chemicals Scheduling (ACCS) (section 52C), which provide recommendations to the Secretary on scheduling matters. The obligations imposed by the TG Act on parties and entities primarily revolve around adherence to the Poisons Standard and the schedules it contains. These schedules classify substances based on the degree of control needed over their availability and use, aimed at minimising risks such as poisoning or misuse. For example, the Act mandates that certain substances cannot be advertised to the public without restrictions, particularly those listed in Schedules 3, 4, 8, 9, and 10. Such regulations ensure that the supply and promotion of these substances are managed in a way that protects public health and safety. Additionally, the Act requires compliance with the Scheduling Policy Framework (SPF), which guides the decision-making process for scheduling matters, although some decisions, such as the minor amendments made in July 2016, may not require public consultation if deemed straightforward. The TG Act and associated regulations also outline specific offences and penalties for breaches of the Poisons Standard and other provisions. For instance, the prohibition on advertising certain substances without the appropriate approvals can result in significant penalties. The exact penalties vary depending on the nature and severity of the breach but can include substantial fines and, in severe cases, criminal charges. The Act also empowers regulatory authorities to take enforcement actions, such as seizing non-compliant goods or imposing bans on the sale or distribution of certain substances. The Act’s provisions ensure that the regulatory framework is robust and capable of addressing non-compliance effectively to uphold public health and safety standards.